Effect of gallamine on cholinergic receptors.
D000109:Acetylcholine / Q000037:antagonists & inhibitors*; D000758:Anesthesia; D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D002415:Cats; D004336:Drug Antagonism; D005703:Gallamine Triethiodide / Q000009:adverse effects / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D006584:Hexamethonium Compounds; D008297:Male; D009467:Neuromuscular Depolarizing Agents; D010276:Parasympatholytics / Q000494:pharmacology; D011433:Propranolol; D051381:Rats; D011955:Receptors, Drug; D013564:Sympathetic Nervous System / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology; D013610:Tachycardia / Q000139:chemically induced
D002395:Catecholamines; D006584:Hexamethonium Compounds; D009467:Neuromuscular Depolarizing Agents; D010276:Parasympatholytics; D011955:Receptors, Drug; D013566:Sympathomimetics; D011433:Propranolol; D000109:Acetylcholine; D005703:Gallamine Triethiodide